You are currently on the new version of our website. Access the old version .

183 Results Found

  • Article
  • Open Access
5 Citations
4,951 Views
10 Pages

27 March 2023

Background and Objectives: TPO-RAs (romiplostim/eltrombopag/avatrombopag) have broadly demonstrated high efficacy rates (59–88%), durable responses (up to three years) and a satisfactory safety profile in clinical trials. The effect of TPO-RAs...

  • Article
  • Open Access
1,531 Views
11 Pages

Objectives: To assess the role of musculoskeletal ultrasound (MSUS) in selecting patients with rheumatoid arthritis (RA) in sustained clinical remission, suitable for tapering of biologic therapy (BT), and monitoring for a subclinical relapse. Method...

  • Article
  • Open Access
1 Citations
2,007 Views
13 Pages

Association between KSHV-Specific Humoral and T Cell Responses with Recurrence of HIV-Associated Kaposi Sarcoma

  • Marie-Claire Mukasine,
  • Gina Mulundu,
  • Musonda Kawimbe,
  • Keagan Mutale,
  • Chibamba Mumba,
  • Salum J. Lidenge and
  • Owen Ngalamika

Kaposi sarcoma (KS) is an AIDS-defining angio-proliferative malignancy, with the Kaposi sarcoma-associated herpes virus (KSHV) as its etiologic agent. Upon treatment with chemotherapy, a proportion of HIV-associated KS patients experience disease rec...

  • Article
  • Open Access
4 Citations
3,028 Views
12 Pages

e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response

  • Sílvia Marcé,
  • Aleix Méndez,
  • Blanca Xicoy,
  • Natalia Estrada,
  • Marta Cabezón,
  • Antonella Luciana Sturla,
  • Miriam Ratia García,
  • Anna Angona,
  • Paula Amat and
  • Silvia Escribano Serrat
  • + 11 authors

29 January 2024

e13a2 and e14a2 are the most frequent transcript types of the BCR::ABL1 fusion gene in chronic myeloid leukemia (CML). The current goal with tyrosine kinase inhibitors (TKI) is to achieve sustained deep molecular response (DMR) in order to discontinu...

  • Review
  • Open Access
705 Views
12 Pages

Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond

  • Matteo Molica,
  • Claudia Simio,
  • Laura De Fazio,
  • Caterina Alati,
  • Massimo Martino and
  • Marco Rossi

21 November 2025

Background: Acute myeloid leukemia (AML) harboring NPM1 mutations constitutes a biologically and clinically distinct subtype, characterized by marked sensitivity to inhibition of the anti-apoptotic protein BCL-2. The introduction of venetoclax, a sel...

  • Article
  • Open Access
45 Views
18 Pages

Toward Personalized Withdrawal of TNF-α Inhibitors in Non-Systemic Juvenile Idiopathic Arthritis: Predictors of Biologic-Free Remission and Flare

  • Ekaterina I. Alexeeva,
  • Irina T. Tsulukiya,
  • Tatyana M. Dvoryakovskaya,
  • Ivan A. Kriulin,
  • Dmitry A. Kudlay,
  • Anna N. Fetisova,
  • Maria S. Botova,
  • Tatyana Y. Kriulina,
  • Elizaveta A. Krekhova and
  • Natalya M. Kondratyeva
  • + 4 authors

10 January 2026

Background: Tumor necrosis factor-α (TNFα) inhibitors have significantly improved outcomes in children with non-systemic juvenile idiopathic arthritis (JIA), achieving long-term clinical remission for many patients. However, the optimal s...

  • Case Report
  • Open Access
3 Citations
7,813 Views
10 Pages

The incidence of inflammatory bowel diseases, such as Crohn’s disease (CD), is increasing worldwide. Despite several new therapeutics to treat CD, many patients fail to respond to their medications and inevitably face surgical resection. While geneti...

  • Article
  • Open Access
1 Citations
3,939 Views
12 Pages

Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur Study

  • María Eva Mingot-Castellano,
  • Gloria García-Donas,
  • Rosa María Campos-Álvarez,
  • María Carmen Fernández-Sánchez de Mora,
  • Josefa Luis-Navarro,
  • Juan Francisco Domínguez-Rodríguez,
  • María del Mar Nieto-Hernández,
  • Irene Sánchez-Bazán,
  • Maria Yera-Cobo and
  • Rocio Cardesa-Cabrera
  • + 11 authors

22 October 2024

Background/objectives: Fostamatinib is a spleen tyrosine kinase (SYK) inhibitor approved for the treatment of adult patients with chronic immune thrombocytopenia (ITP). There is little information about dose tapering and sustained remission after dis...

  • Article
  • Open Access
753 Views
10 Pages

Phosphatidylinositol-3-kinase (PI3K) inhibition has emerged as a therapeutic option against indolent lymphoma, including relapsed follicular lymphoma (FL). While inhibition of active signaling in the lymphoma cell represents the primary mode of actio...

  • Review
  • Open Access
12 Citations
6,663 Views
30 Pages

8 February 2020

Human immunodeficiency virus (HIV-1) indefinitely persists, despite effective antiretroviral therapy (ART), within a small pool of latently infected cells. These cells often display markers of immunologic memory and harbor both replication-competent...

  • Article
  • Open Access
1,306 Views
27 Pages

Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions

  • Shubhasmita Mohapatra,
  • Adrian Guerrero,
  • Neha Rahman,
  • Khondoker Takia Zaman,
  • Jing Wu,
  • Callistus Onyeagba,
  • Chanyue Hu,
  • Matteo Pellegrini,
  • Jayaram Vankudoth and
  • Seiya Kitamura
  • + 3 authors

30 October 2025

Reprogramming of macrophages into the inflammatory state (also known as M1) is currently considered as an effective way of eliminating cancer cells, but systemic deployment of this strategy is likely to induce dangerous autoimmune reactions. Conseque...

  • Systematic Review
  • Open Access
3,068 Views
20 Pages

Challenges and Opportunities in Achieving Asthma Remission

  • Elena Cojocaru,
  • Raluca Ioana Arcana,
  • Steluta Radu,
  • Antigona Carmen Trofor and
  • Cristian Cojocaru

20 April 2025

Background: Asthma is a chronic inflammatory disorder in millions of individuals across the globe with high morbidity, mortality, and health care costs. Despite advances in asthma treatment, long-term remission is a challenging target to achieve. Obj...

  • Article
  • Open Access
1,091 Views
19 Pages

Sex-Specific Real-Life Profiling in Vedolizumab, Ustekinumab, and Tofacitinib Effectiveness in Ulcerative Colitis

  • Antonio Tursi,
  • Raffaele Pellegrino,
  • Giammarco Mocci,
  • Edoardo Vincenzo Savarino,
  • Giovanni Maconi,
  • Walter Elisei,
  • Antonietta Gerarda Gravina and
  • Italian Network for Inflammatory Bowel Diseases (IN-IBD)

22 October 2025

Background: This study aimed to explore whether differences exist between males and females in a cohort of bio-experienced UC patients treated with vedolizumab (VDZ), ustekinumab (UST), or tofacitinib (TOFA) in a 48-week retrospective study. Methods:...

  • Article
  • Open Access
8 Citations
4,032 Views
13 Pages

New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”

  • Ana de Hollanda,
  • Albert Lecube,
  • Miguel Angel Rubio,
  • Enric Sánchez,
  • Núria Vilarrasa,
  • José Gregorio Oliva,
  • María Luisa Fernández-Soto,
  • Jordi Salas-Salvadó,
  • María D. Ballesteros-Pomar and
  • Andreea Ciudin
  • + 34 authors

9 April 2020

Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after bariatric surgery and to eva...

  • Article
  • Open Access
168 Views
15 Pages

6 January 2026

Background/Objectives: In recent years, the concept of clinical remission under treatment in asthma has gained increasing attention. It is defined as the absence of exacerbations, asthma symptoms, and oral corticosteroid use for at least 12 months, t...

  • Feature Paper
  • Review
  • Open Access
3 Citations
9,875 Views
15 Pages

24 February 2023

Despite evolution in treatment options and improved understanding of pathophysiology, the treatment of type 2 diabetes remains unsatisfactory. Current management guidelines complicated by clinical inertia have resulted in over half of patients failin...

  • Review
  • Open Access
10 Citations
9,372 Views
21 Pages

Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches

  • Lucia Centanni,
  • Clelia Cicerone,
  • Fabrizio Fanizzi,
  • Ferdinando D’Amico,
  • Federica Furfaro,
  • Alessandra Zilli,
  • Tommaso Lorenzo Parigi,
  • Laurent Peyrin-Biroulet,
  • Silvio Danese and
  • Mariangela Allocca

10 January 2025

Inflammatory bowel diseases (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC) are chronic, relapsing conditions characterized by dysregulated immune responses and persistent intestinal inflammation. This review aims to examine ne...

  • Article
  • Open Access
6 Citations
3,515 Views
16 Pages

Longitudinal CT Imaging to Explore the Predictive Power of 3D Radiomic Tumour Heterogeneity in Precise Imaging of Mantle Cell Lymphoma (MCL)

  • Catharina Silvia Lisson,
  • Christoph Gerhard Lisson,
  • Sherin Achilles,
  • Marc Fabian Mezger,
  • Daniel Wolf,
  • Stefan Andreas Schmidt,
  • Wolfgang M. Thaiss,
  • Johannes Bloehdorn,
  • Ambros J. Beer and
  • Stephan Stilgenbauer
  • + 2 authors

13 January 2022

The study’s primary aim is to evaluate the predictive performance of CT-derived 3D radiomics for MCL risk stratification. The secondary objective is to search for radiomic features associated with sustained remission. Included were 70 patients:...

  • Article
  • Open Access
3 Citations
2,785 Views
15 Pages

Association between Corrected QT Interval and C-Reactive Protein in Patients with Inflammatory Bowel Diseases

  • Angelo Viscido,
  • Annalisa Capannolo,
  • Renata Petroni,
  • Gianpiero Stefanelli,
  • Giulia Zerboni,
  • Massimo De Martinis,
  • Stefano Necozione,
  • Maria Penco,
  • Giuseppe Frieri and
  • Giovanni Latella
  • + 1 author

30 July 2020

Background and objectives: Electrocardiograph abnormalities (i.e., QT interval prolongation) have been described in inflammatory bowel diseases (IBD). We aimed to measure the QT interval in a cohort of patients with IBD and to analyze its relationshi...

  • Review
  • Open Access
102 Citations
10,224 Views
14 Pages

The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn’s Disease: A Review

  • Amber MacLellan,
  • Jessica Connors,
  • Shannan Grant,
  • Leah Cahill,
  • Morgan G. I. Langille and
  • Johan Van Limbergen

1 May 2017

Crohn’s disease (CD), a form of inflammatory bowel disease (IBD), is thought to arise from a complex interaction of genetics, the gut microbiome, and environmental factors, such as diet. There is clear evidence that dietary intervention is successful...

  • Article
  • Open Access
6 Citations
2,531 Views
11 Pages

Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study

  • Letícia Rodrigues de Souza,
  • Daniela Oliveira Magro,
  • Fábio Vieira Teixeira,
  • Rogério Serafim Parra,
  • Eron Fábio Miranda,
  • Omar Féres,
  • Rogério Saad-Hossne,
  • Giedre Soares Prates Herrerias,
  • Renato Mitsunori Nisihara and
  • Claudio Saddy Rodrigues Coy
  • + 2 authors

Despite some variability in ideal serum Adalimumab (ADA) concentrations, there is increasing evidence that higher concentrations of anti-TNF-α agents can be associated with sustained efficacy, and low or undetectable levels may lead to loss of...

  • Case Report
  • Open Access
877 Views
8 Pages

Topical Chlormethine Gel in the Treatment of Lymphomatoid Papulosis: A Case Report and Literature Review

  • Miriam Teoli,
  • Martina Caviglia,
  • Federica Rega,
  • Luca Barbieri,
  • Marco Ardigò and
  • Victor Desmond Mandel

29 July 2025

Background: Lymphomatoid papulosis (LyP) is a primary cutaneous CD30-positive T-cell lymphoproliferative disorder presenting with self-healing erythematous papulonodular lesions that may ulcerate and scar. Treatment varies by lesion extent, location,...

  • Article
  • Open Access
7 Citations
3,777 Views
17 Pages

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

  • María Chaparro,
  • Iria Baston-Rey,
  • Estela Fernández Salgado,
  • Javier González García,
  • Laura Ramos,
  • María Teresa Diz-Lois Palomares,
  • Federico Argüelles-Arias,
  • Eva Iglesias Flores,
  • Mercedes Cabello and
  • Saioa Rubio Iturria
  • + 58 authors

3 August 2022

Ustekinumab has shown efficacy in Crohn’s Disease (CD) patients. To identify patient profiles of those who benefit the most from this treatment would help to position this drug in the therapeutic paradigm of CD and generate hypotheses for futur...

  • Article
  • Open Access
7 Citations
3,196 Views
10 Pages

Arterial Hypertension in Morbid Obesity after Bariatric Surgery: Five Years of Follow-Up, a Before-And-After Study

  • Angeles Arias,
  • Cristobalina Rodríguez-Álvarez,
  • Enrique González-Dávila,
  • Alfonso Acosta-Torrecilla,
  • M. Mercedes Novo-Muñoz and
  • Natalia Rodríguez-Novo

Background: Arterial hypertension (HTN) is common among morbidly obese patients undergoing bariatric surgery. The aim of this study is to analyse the prevalence and evolution of HTN and weight loss in patients suffering from morbid obesity before and...

  • Review
  • Open Access
2,065 Views
19 Pages

Kidney Transplantation in Patients with Multiple Myeloma: Current Evidence, Challenges, and Future Directions

  • Natacha Rodrigues,
  • Manuel Silva,
  • Carolina Branco,
  • Sofia Barreto,
  • Telma Pais and
  • José António Lopes

25 September 2025

Renal involvement is an important complication of multiple myeloma (MM) and is related not only to worse clinical outcomes but also to lower quality of life, particularly when progressing to end-stage renal disease. Traditionally, MM patients were no...

  • Case Report
  • Open Access
8 Citations
2 Pages

Pure Red Cell Aplasia and Associated Thymoma

  • Cristian Rosu,
  • Sandra Cohen,
  • Caroline Meunier,
  • Denise Ouellette,
  • Gilles Beauchamp and
  • George Rakovich

Pure red cell aplasia is a rare cause of anemia, caused by an absence of red blood cell precursors in the bone marrow. It is usually a paraneoplastic syndrome, associated most commonly with large-cell granular lymphocyte leukemia but also thymoma. Fo...

  • Review
  • Open Access
6 Citations
5,658 Views
20 Pages

13 December 2021

Background: It is now accepted that the optimum treatment goal for rheumatoid arthritis (RA) is sustained remission, as this has been shown to be associated with the best patient outcomes. There is little guidance on how to manage patients once remis...

  • Editorial
  • Open Access
8 Citations
2,313 Views
4 Pages

15 November 2021

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) pandemic has raged for almost two years, with few signs of a sustained abatement or remission [...]

  • Article
  • Open Access
4 Citations
2,394 Views
10 Pages

Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C

  • Giuseppe Losurdo,
  • Andrea Iannone,
  • Antonella Contaldo,
  • Michele Barone,
  • Enzo Ierardi,
  • Alfredo Di Leo and
  • Mariabeatrice Principi

2 December 2020

Concomitant inflammatory bowel disease (IBD) and hepatitis C virus (HCV) infection is a relevant comorbidity since IBD itself exposes to a high risk of liver damage. We aimed to evaluate liver stiffness (LS) in IBD-HCV after antiviral treatment. We e...

  • Article
  • Open Access
4 Citations
3,005 Views
15 Pages

Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis

  • Binyao Chen,
  • Shizhao Yang,
  • Lei Zhu,
  • Xuening Peng,
  • Daquan He,
  • Tianyu Tao and
  • Wenru Su

11 November 2022

Long-term systemic glucocorticoids and non-specific immunosuppressants remain the mainstay of treatment for refractory scleritis, and result in serious side-effects and repeated inflammation flares. To assess the efficacy and safety of additional ada...

  • Article
  • Open Access
2 Citations
2,670 Views
10 Pages

The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors

  • Andrea Latini,
  • Giada De Benedittis,
  • Paola Conigliaro,
  • Chiara Bonini,
  • Chiara Morgante,
  • Maria Iacovantuono,
  • Arianna D’Antonio,
  • Alberto Bergamini,
  • Giuseppe Novelli and
  • Maria Sole Chimenti
  • + 2 authors

12 February 2024

The vitamin D receptor (VDR), binding to the active form of the vitamin, promotes the transcription of numerous genes involved in the proliferation of immune cells, cytokine production and lymphocyte activation. It is known that vitamin D deficiency...

  • Article
  • Open Access
2 Citations
2,469 Views
11 Pages

Evaluation of Clinical Factors Predictive of Diabetes Remission Following Bariatric Surgery

  • Isabel Mateo-Gavira,
  • Esteban Sánchez-Toscano,
  • Mª Ángeles Mayo-Ossorio,
  • José Manuel Pacheco-García,
  • Jose Arturo Prada-Oliveira and
  • Francisco Javier Vílchez-López

Bariatric surgery is an effective treatment for achieving significant weight loss and improving metabolic comorbidities such as type 2 diabetes mellitus (T2DM). The aim of our study was to investigate clinical factors related to T2DM remission in obe...

  • Systematic Review
  • Open Access
20 Citations
11,295 Views
20 Pages

Dietary Interventions in Ulcerative Colitis: A Systematic Review of the Evidence with Meta-Analysis

  • Marta Herrador-López,
  • Rafael Martín-Masot and
  • Víctor Manuel Navas-López

28 September 2023

(1) Background: Ulcerative colitis (UC) is a chronic colon inflammation caused by genetic and environmental factors, including diet. This systematic review and meta-analysis aims to assess the impact of diet on UC management in children and adults (2...

  • Article
  • Open Access
21 Citations
10,553 Views
30 Pages

Alpha-1 Acid Glycoprotein Reduction Differentiated Recovery from Remission in a Small Cohort of Cats Treated for Feline Infectious Peritonitis

  • Diane D. Addie,
  • Carla Silveira,
  • Charlotte Aston,
  • Pauline Brauckmann,
  • Johanna Covell-Ritchie,
  • Chris Felstead,
  • Mark Fosbery,
  • Caryn Gibbins,
  • Kristina Macaulay and
  • James McMurrough
  • + 2 authors

1 April 2022

Feline infectious peritonitis (FIP) is a systemic immune-mediated inflammatory perivasculitis that occurs in a minority of cats infected with feline coronavirus (FCoV). Various therapies have been employed to treat this condition, which was previousl...

  • Brief Report
  • Open Access
2 Citations
2,431 Views
8 Pages

Physical Function of RA patients Tapering Treatment—A Post Hoc Analysis of the Randomized Controlled RETRO Trial

  • Marlene Stephan,
  • Koray Tascilar,
  • Melek Yalcin-Mutlu,
  • Melanie Hagen,
  • Judith Haschka,
  • Michaela Reiser,
  • Fabian Hartmann,
  • Arnd Kleyer,
  • Axel J. Hueber and
  • Bernhard Manger
  • + 20 authors

28 May 2023

Several studies have shown that tapering or stopping disease-modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) patients in sustained remission is feasible. However, tapering/stopping bears the risk of decline in physical function a...

  • Case Report
  • Open Access
2,035 Views
9 Pages

“Lazarus Response” When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin Pregnancy

  • Radu Andrei Tomai,
  • Sabina Iluta,
  • Adrian Bogdan Tigu,
  • Madalina Nistor,
  • Anamaria Bancos,
  • Diana Cenariu,
  • Ciprian Jitaru,
  • Sergiu Patcas,
  • Delia Dima and
  • David Kegyes
  • + 5 authors

20 September 2024

Background: Spontaneous remission of cancer is a rare and poorly understood phenomenon characterized by complete or partial remission of a malignancy in the absence of or with inadequate treatment. The underlying mechanism for such occurrences is poo...

  • Review
  • Open Access
6 Citations
5,742 Views
26 Pages

Interventions during Early Infection: Opening a Window for an HIV Cure?

  • Christopher R. Hiner,
  • April L. Mueller,
  • Hang Su and
  • Harris Goldstein

9 October 2024

Although combination antiretroviral therapy (ART) has been a landmark achievement for the treatment of human immunodeficiency virus (HIV), an HIV cure has remained elusive. Elimination of latent HIV reservoirs that persist throughout HIV infection is...

  • Article
  • Open Access
20 Citations
3,937 Views
15 Pages

1 October 2019

In spite of the lack of evidence of diet therapy efficacy to sustain remission of ulcerative colitis (UC), the dietary counseling may be beneficial, as a number of patients restrict intake of some products with no medical consultation. The aim of the...

  • Review
  • Open Access
11 Citations
3,942 Views
13 Pages

Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells

  • Mohammad Houshmand,
  • Alireza Kazemi,
  • Ali Anjam Najmedini,
  • Muhammad Shahzad Ali,
  • Valentina Gaidano,
  • Alessandro Cignetti,
  • Carmen Fava,
  • Daniela Cilloni,
  • Giuseppe Saglio and
  • Paola Circosta

11 December 2021

Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent population that are resistant to tyrosine kinase inhibitors (TKI). When TKI therapy is discontinued in CML patients in deep, sustained and apparently stable molecular remission,...

  • Article
  • Open Access
4 Citations
2,598 Views
11 Pages

Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study

  • Monica State,
  • Paul Balanescu,
  • Theodor Voiosu,
  • Andreea Bengus,
  • Andrei Voiosu,
  • Andrei Coman,
  • Petronel Mustatea,
  • Lucian Negreanu,
  • Radu Bogdan Mateescu and
  • Cristiana Popp

Background: Histologic activity has emerged as an aspirational therapeutic goal in ulcerative colitis management. It is not yet a formal treatment target in ulcerative colitis. However, it could be used as an adjunct to mucosal healing to represent a...

  • Case Report
  • Open Access
14 Citations
2 Pages

Total Remission of Severe Immune Thrombocytopenia after Short Term Treatment with Romiplostim

  • Efthymia Vlachaki,
  • Vaia Papageorgiou,
  • Filippos Klonizakis,
  • Maria Spandonidou,
  • Sofia Chisan,
  • Evaggelia Vetsiou and
  • Elissavet Ioannidou

27 October 2011

Immune thrombocytopenia (ITP) in adults is an acquired chronic immune-mediated disorder defined by isolated thrombocytopenia. In recent years, an improved understanding of the pathophysiology of ITP has been achieved and it is now accepted that the d...

  • Article
  • Open Access
3,244 Views
14 Pages

Advancing the Treatment of Adult Steroid-Resistant Nephrotic Syndrome: The Role of Rituximab

  • Dmytro Ivanov,
  • Mariia Ivanova,
  • Olga Chub,
  • Iryna Zavalna,
  • Natalia Biljak,
  • Yelizaveta Lagodych and
  • Isa Jabbarli

Background: Steroid-resistant nephrotic syndrome (SRNS) in adults presents a significant therapeutic challenge, often leading to end-stage kidneys. This study aims to evaluate the clinical outcomes of rituximab (RTX) administration as an alternative...

  • Article
  • Open Access
9 Citations
2,705 Views
18 Pages

The aim of the current study was to examine the effects of length of abstinence on decision making (impulsive choice) and response inhibition (impulsive action) in former opiate users (OU). Participants included 45 OU in early remission [0–12 m...

  • Article
  • Open Access
1,146 Views
13 Pages

Early Renal Remission Is Associated with Increased Likelihood of Subsequent Remission in Lupus Nephritis: Single-Centre Observational Study in Australia

  • Shiori Nakagawa,
  • Emily K. Yeung,
  • Alberta Hoi,
  • Eric F. Morand,
  • Joanna R. Kent and
  • Rangi Kandane-Rathnayake

2 October 2025

Reliable clinical markers for predicting sustained renal remission remain poorly understood in patients with lupus nephritis (LN). We investigated whether achieving complete renal remission (CRR) within 6 months of induction therapy, compared to with...

  • Article
  • Open Access
28 Citations
3,775 Views
9 Pages

Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: A Study from the International Registry of Childhood CML

  • Frédéric Millot,
  • Meinolf Suttorp,
  • Stéphanie Ragot,
  • Guy Leverger,
  • Jean-Hugues Dalle,
  • Caroline Thomas,
  • Nathalie Cheikh,
  • Brigitte Nelken,
  • Marilyne Poirée and
  • Geneviève Plat
  • + 3 authors

15 August 2021

Within the International Registry of Childhood Chronic Myeloid Leukemia (CML), we identified 18 patients less than 18 years old at diagnosis of CML who were in the chronic phase and exhibiting a sustained deep molecular response (DMR) to imatinib def...

  • Communication
  • Open Access
3 Citations
2,404 Views
11 Pages

Gut Microbiota Composition Changes following Discontinuation of Exclusive Enteral Nutrition in Children with Crohn’s Disease

  • Sara Sila,
  • Marko Jelić,
  • Ivana Trivić,
  • Arjana Tambić Andrašević,
  • Sanja Kolaček and
  • Iva Hojsak

This study aims to determine changes in the intestinal microbiota of children with Crohn’s disease (CD) before and during exclusive enteral nutrition (EEN) and after its discontinuation. A total of 14 newly diagnosed children with CD (median ag...

  • Review
  • Open Access
1 Citations
9,454 Views
31 Pages

New Interleukin-23 Antagonists’ Use in Crohn’s Disease

  • Laura Biskup,
  • Jan Semeradt,
  • Jagoda Rogowska,
  • Wiktoria Chort,
  • Łukasz Durko and
  • Ewa Małecka-Wojciesko

22 March 2025

Crohn’s disease (CD) is a chronic inflammatory condition of the digestive tract, driven by an imbalance in immune system regulation, where proinflammatory interleukin-23 (IL-23) plays an essential role. Selective new IL-23 inhibitors, including...

  • Article
  • Open Access
1,664 Views
11 Pages

Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia

  • Tong-Yoon Kim,
  • Gi-June Min,
  • Young-Woo Jeon,
  • Seung-Ah Yahng,
  • Seok-Goo Cho,
  • Jong-Mi Lee,
  • Myungshin Kim and
  • Ki-Seong Eom

Background/Objectives: Anti-CD20 monoclonal antibodies combined with alkylator-based chemotherapy enhance survival in chronic lymphocytic leukemia (CLL). However, the risks of infection and bone marrow suppression may mean that new, targeted therapie...

  • Review
  • Open Access
2,577 Views
17 Pages

The Struggle Between Chimeric Antigen Receptor T-Cell Therapy and Neurological Complications in Acute Lymphoblastic Leukemia Treatment

  • Norwin Kubick,
  • Marzena Łazarczyk,
  • Omar Awad,
  • Michał Ławiński,
  • Jarosław Olav Horbańczuk,
  • Mariusz Sacharczuk,
  • Atanas G. Atanasov,
  • Piotr Religa and
  • Michel Edwar Mickael

Acute lymphoblastic leukemia (ALL) accounts for approximately 25% of childhood cancers and 20% of leukemia cases in adults, with a higher prevalence in males than females. It is characterized by symptoms such as fatigue, fever, and bone pain and pose...

  • Review
  • Open Access
2 Citations
2,824 Views
14 Pages

Castleman Disease—Still More Questions than Answers: A Case Report and Review of the Literature

  • Mariusz Sikora,
  • Nel Dąbrowska-Leonik,
  • Piotr Buda,
  • Beata Wolska-Kuśnierz,
  • Karina Jahnz-Różyk,
  • Małgorzata Pac and
  • Ewa Więsik-Szewczyk

18 April 2025

Background: Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder with diverse clinical presentations, often posing significant diagnostic challenges. Methods: We report the case of a 20-year-old woman who first pres...

of 4